The Valley Desk

Clinical trial reportEndocrine-related cancerPublished

Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source

Publication record

Type
Clinical trial report
Venue
Endocrine-related cancer
Published
Subject terms
Humans; Thyroid Neoplasms; Iodine Radioisotopes; Piperidines; Quinazolines; Antineoplastic Agents; Double-Blind Method; Adult; Aged; Middle Aged; Female; Male
PubMed ID
38828895
PubMed Central ID
PMC11301419
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal